Bumper Offer - Urjas oil Just @ Rs. 1
Ocupol DX Eye Ointment is a commercial drug that is prescribed in the form of Ointment. Other than this, Ocupol DX Eye Ointment has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Ocupol DX Eye Ointment is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Ocupol DX Eye Ointment are Skin scar, Dryness, Itching or burning. Some other side effects of Ocupol DX Eye Ointment have been listed ahead. Usually, these side effects of Ocupol DX Eye Ointment go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Ocupol DX Eye Ointment's effect during pregnancy is Unknown and Unknown while nursing. It is important to know if Ocupol DX Eye Ointment has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ocupol DX Eye Ointment related warnings section.
Ocupol DX Eye Ointment is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease, Infections as it can result in adverse effects. The section on Ocupol DX Eye Ointment contraindications lists all such conditions.
Drug interactions for Ocupol DX Eye Ointment have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Ocupol DX Eye Ointment is considered not safe while driving, and is not addictive.
Ocupol DX Eye Ointment is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ocupol DX Eye Ointment is used -
Severe
Moderate
Mild
Common
Is the use of Ocupol DX Eye Ointment safe for pregnant women?
No research has not been done till date on the safety of Ocupol DX for pregnant women. So its effects on pregnant women are unknown.
Is the use of Ocupol DX Eye Ointment safe during breastfeeding?
No research work has been carried out till date on effect of Ocupol DX on breastfeeding women. So it is not known whether taking Ocupol DX will cause side effects or not.
What is the effect of Ocupol DX Eye Ointment on the Kidneys?
Ocupol DX rarely harms the kidneys.
What is the effect of Ocupol DX Eye Ointment on the Liver?
Ocupol DX is not harmful for the liver.
What is the effect of Ocupol DX Eye Ointment on the Heart?
Ocupol DX is not harmful for the heart.
Ocupol DX Eye Ointment should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ocupol DX Eye Ointment unless your doctor advises you to do so -
Is this Ocupol DX Eye Ointment habit forming or addictive?
Forming a habit of Ocupol DX Eye Ointment has not been reported.
Interaction between Food and Ocupol DX Eye Ointment
Taking Ocupol DX Eye Ointment with food is safe.
Interaction between Alcohol and Ocupol DX Eye Ointment
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ocupol DX Eye Ointment.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Chloromycetin sodium succinate (chaloramphenicol sodium succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 739-742
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Decadron® (dexamethasone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hemady™ (dexamethasone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hexadrol® (dexamethasone sodium phosphate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Polymyxin B
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 759
